• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌细胞如何对阳离子溶细胞肽产生耐药性:原来是糖的作用!

How Cancer Cells Become Resistant to Cationic Lytic Peptides: It's the Sugar!

机构信息

Department of Chemistry, College of Sciences, NC State University, Raleigh, NC 27695, USA; Comparative Medicine Institute, NC State University, Raleigh, NC 27695, USA.

出版信息

Cell Chem Biol. 2017 Feb 16;24(2):121-122. doi: 10.1016/j.chembiol.2017.01.009.

DOI:10.1016/j.chembiol.2017.01.009
PMID:28212754
Abstract

In this issue of Cell Chemical Biology, Ishikawa et al. (2017) demonstrate that the loss of cell-surface anionic saccharides can impart resistance toward anticancer peptides. This study provides the first insight into potential resistance mechanisms toward cationic lytic peptides and highlights the important, yet previously unappreciated, role cell-surface glycans can play in cellular resistance mechanisms.

摘要

在本期《细胞化学生物学》中,Ishikawa 等人(2017)证明了细胞表面阴离子糖的缺失可以赋予癌细胞对抗癌肽的抗性。这项研究首次揭示了阳离子溶细胞肽潜在的耐药机制,并强调了细胞表面聚糖在细胞耐药机制中重要但以前未被重视的作用。

相似文献

1
How Cancer Cells Become Resistant to Cationic Lytic Peptides: It's the Sugar!癌细胞如何对阳离子溶细胞肽产生耐药性:原来是糖的作用!
Cell Chem Biol. 2017 Feb 16;24(2):121-122. doi: 10.1016/j.chembiol.2017.01.009.
2
Glycan Alteration Imparts Cellular Resistance to a Membrane-Lytic Anticancer Peptide.聚糖修饰赋予细胞膜溶解抗癌肽细胞抗性。
Cell Chem Biol. 2017 Feb 16;24(2):149-158. doi: 10.1016/j.chembiol.2016.12.009. Epub 2017 Jan 12.
3
Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.组氨酸富含溶菌肽对耐药菌的活性和选择性。
Arch Microbiol. 2012 Sep;194(9):769-78. doi: 10.1007/s00203-012-0810-5. Epub 2012 Apr 12.
4
Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.通过瘤内和全身接种富含组氨酸且依赖pH的宿主防御样溶菌肽抑制小鼠体内人实体瘤生长。
Cancer Res. 2009 Apr 15;69(8):3458-63. doi: 10.1158/0008-5472.CAN-08-3021. Epub 2009 Apr 7.
5
Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane.富含赖氨酸或精氨酸的促凋亡阳离子宿主防御肽通过破坏肿瘤细胞膜逆转耐药性。
Amino Acids. 2017 Sep;49(9):1601-1610. doi: 10.1007/s00726-017-2453-y. Epub 2017 Jun 29.
6
Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway.含阳离子肽的两亲性发光三芳基环金属铱(III)配合物的设计与合成:通过钙依赖性途径诱导和检测细胞死亡
Bioconjug Chem. 2015 May 20;26(5):857-79. doi: 10.1021/acs.bioconjchem.5b00095. Epub 2015 May 5.
7
Isoleucine/leucine residues at "a" and "d" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide.七肽重复序列中“a”和“d”位置的异亮氨酸/亮氨酸残基对于一种短抗癌溶细胞肽的溶细胞活性至关重要。
Amino Acids. 2017 Jan;49(1):193-202. doi: 10.1007/s00726-016-2350-9. Epub 2016 Oct 24.
8
In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines.膜活性阳离子肽抗癌活性的体外表征。I. 肽介导的细胞毒性以及阿霉素对野生型和过表达P-糖蛋白的肿瘤细胞系的肽增强细胞毒性活性。
Anticancer Drug Des. 2000 Apr;15(2):151-60.
9
Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.具有选择性抗肿瘤机制的抗菌肽:抗癌应用前景
Oncotarget. 2017 Jul 11;8(28):46635-46651. doi: 10.18632/oncotarget.16743.
10
New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.基于D,L-两亲性螺旋基序的新型溶细胞肽与正常细胞相比,优先杀死肿瘤细胞。
Biochemistry. 2003 Aug 12;42(31):9346-54. doi: 10.1021/bi027212o.

引用本文的文献

1
Are peptides a solution for the treatment of hyperactivated JAK3 pathways?肽类药物能否成为治疗过度激活的 JAK3 通路的方法?
Inflammopharmacology. 2019 Jun;27(3):433-452. doi: 10.1007/s10787-019-00589-2. Epub 2019 Mar 30.